CYTOF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
326.35K
VTVT
Price
$15.54
Change
-$0.03 (-0.19%)
Updated
Jul 25 closing price
Capitalization
40.67M
Interact to see
Advertisement

CYTOF vs VTVT

Header iconCYTOF vs VTVT Comparison
Open Charts CYTOF vs VTVTBanner chart's image
Altamira Therapeutics
Price$0.07
Change-$0.00 (-0.00%)
Volume$3.01K
Capitalization326.35K
vTv Therapeutics
Price$15.54
Change-$0.03 (-0.19%)
Volume$2.18K
Capitalization40.67M
CYTOF vs VTVT Comparison Chart in %
Loading...
CYTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTOF vs. VTVT commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTOF is a Hold and VTVT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CYTOF: $0.07 vs. VTVT: $15.54)
Brand notoriety: CYTOF and VTVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTOF: 37% vs. VTVT: 38%
Market capitalization -- CYTOF: $326.35K vs. VTVT: $40.67M
CYTOF [@Biotechnology] is valued at $326.35K. VTVT’s [@Biotechnology] market capitalization is $40.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTOF’s FA Score shows that 1 FA rating(s) are green whileVTVT’s FA Score has 0 green FA rating(s).

  • CYTOF’s FA Score: 1 green, 4 red.
  • VTVT’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTOF is a better buy in the long-term than VTVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTOF’s TA Score shows that 3 TA indicator(s) are bullish while VTVT’s TA Score has 3 bullish TA indicator(s).

  • CYTOF’s TA Score: 3 bullish, 6 bearish.
  • VTVT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VTVT is a better buy in the short-term than CYTOF.

Price Growth

CYTOF (@Biotechnology) experienced а -29.93% price change this week, while VTVT (@Biotechnology) price change was -7.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CYTOF is expected to report earnings on Apr 30, 2025.

VTVT is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTVT($40.7M) has a higher market cap than CYTOF($326K). VTVT YTD gains are higher at: 12.538 vs. CYTOF (-36.652).
CYTOFVTVTCYTOF / VTVT
Capitalization326K40.7M1%
EBITDAN/A-23.41M-
Gain YTD-36.65212.538-292%
P/E Ratio0.05N/A-
RevenueN/A17K-
Total CashN/A31.1M-
Total DebtN/A125K-
FUNDAMENTALS RATINGS
CYTOF vs VTVT: Fundamental Ratings
CYTOF
VTVT
OUTLOOK RATING
1..100
153
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9660
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTOF's Valuation (8) in the Biotechnology industry is significantly better than the same rating for VTVT (94). This means that CYTOF’s stock grew significantly faster than VTVT’s over the last 12 months.

CYTOF's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VTVT (100). This means that CYTOF’s stock grew similarly to VTVT’s over the last 12 months.

VTVT's SMR Rating (98) in the Biotechnology industry is in the same range as CYTOF (100). This means that VTVT’s stock grew similarly to CYTOF’s over the last 12 months.

VTVT's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for CYTOF (96). This means that VTVT’s stock grew somewhat faster than CYTOF’s over the last 12 months.

VTVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CYTOF (100). This means that VTVT’s stock grew similarly to CYTOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTOFVTVT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CYTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TITN20.120.31
+1.56%
Titan Machinery
LION6.540.04
+0.62%
Lionsgate Studios Corp
WES40.760.11
+0.27%
Western Midstream Partners LP
GBR0.97-0.01
-0.58%
New Concept Energy
OII22.67-1.28
-5.34%
Oceaneering International